drug-use

Documents about drug-use

• Speak and You Shall Predict: Evidence That Speech at Initial Cocaine Abstinence Is a Biomarker of Long-Term Drug Use Behavior.#327187NCBI PubMed Central
• Prevalence of criminal legal involvement among emergency department patients: Insights from the National Survey on Drug Use and Health 2021-2023.#354810NCBI PubMed Central
• Prevalence, predictors, and academic-related indicators associated with psychoactive drug use among students in tertiary institutions in Rivers State, Nigeria.#645614NCBI PubMed Central
• Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study#812689ClinicalTrials.gov
• Olfactory Function and Model-Based Behavior in People Living With HIV and SUD#848366ClinicalTrials.gov
• Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic Insomnia#855950ClinicalTrials.gov
• Effectiveness of Reducing Smoking in Facilitating Smoking Cessation in Adolescents - 2#887866ClinicalTrials.gov
• NightCAP: Reducing Hypnotic Drug Use and Improving Night-time Care#888181ClinicalTrials.gov
• Prevention of Drug Use in Adolescence: Intervening in Parenting Styles#904553ClinicalTrials.gov
• A Transtheoretical Model Group Therapy for Cocaine#906392ClinicalTrials.gov
• Naloxone Treatment in Skåne County - Effect on Drug-related Mortality and Overdose-related Complications#910320ClinicalTrials.gov
• 21 CFR Part 333 — Topical Antimicrobial Drug Products for Over-the-Counter Human Use#506824Code of Federal Regulations (eCFR)
• 21 CFR Part 344 — Topical Otic Drug Products for Over-the-Counter Human Use#506831Code of Federal Regulations (eCFR)
• 21 CFR Part 347 — Skin Protectant Drug Products for Over-the-Counter Human Use#506833Code of Federal Regulations (eCFR)
• 21 CFR Part 348 — External Analgesic Drug Products for Over-the-Counter Human Use#506834Code of Federal Regulations (eCFR)
• 21 CFR Part 357 — Miscellaneous Internal Drug Products for Over-the-Counter Human Use#506839Code of Federal Regulations (eCFR)
• 21 CFR Part 358 — Miscellaneous External Drug Products for Over-the-Counter Human Use#506840Code of Federal Regulations (eCFR)
• 42 U.S.C. § 247b-15 — Surveillance and education regarding infections associated with illicit drug use and other risk factors#595378US Code (LII)
• DAST-28 severity and injection-related harm risks among people using psychoactive substances in psychiatric and correctional settings in Mongolia: a multicenter cross-sectional study#676364Europe PMC
• Project Orleu: Reducing Intersectional and HIV Stigma Among Health Care Providers and High Risk Women Who Use Drugs in Kazakhstan#877219ClinicalTrials.gov
• A Legal Analysis of the Status of Pregnant Women with Substance Use Disorders in the Iranian Legal System#1052310DOAJ
• Continuum of care in hospitalized patients with opioid or stimulant use disorder and infectious complications of drug use-substance use/infectious disease integrated clinic compared to treatment as usual to prevent infection-related readmission (CHOICE-STAR): a study protocol for an effectiveness-implementation randomized controlled trial.#660NCBI PubMed Central
• 21 CFR Part 338 — Nighttime Sleep-Aid Drug Products for Over-the-Counter Human Use#506827Code of Federal Regulations (eCFR)
• 21 CFR Part 352 — Sunscreen Drug Products for Over-the-Counter Human Use [Stayed Indefinitely]#506837Code of Federal Regulations (eCFR)
• Drugs and Criminal Responsibility#302441Scholarship@Vanderbilt Law
• Learning from Alcohol Rewards: Neural Signatures of Drug-Related Reward Prediction Errors in Alcohol Use Disorder#382930OSF
• Nasal drug products and methods of their use — Opiant Pharmaceuticals, Inc. (US20210275519A1)#607364Google Patents
• Predicting the geographical distribution of drug use disorder in Sweden from the geographical variation in social deprivation, genetic risk and urbanization.#785720NCBI PubMed Central
• Drug Use-Results Survey in Participants Infected With Hepatitis C Virus Genotype 2#826060ClinicalTrials.gov
• Sodium Risedronate Tablets - Special Drug Use Surveillance in Patients With Osseous Paget's Disease (All-case Surveillance) -48-week Surveillance -#829105ClinicalTrials.gov
• Evaluation of the Use of ACOTEC Drug-Eluting Balloon Litos ® in Below-The-Knee Arteries to Treat Critical Limb Ischemia#858635ClinicalTrials.gov
• The Rise of Ride Sharing Companies and Trends in Impaired Driving Accidents#876065ClinicalTrials.gov
• A Pilot Trial of Modafinil for Treatment of Methamphetamine Dependence#899359ClinicalTrials.gov
• Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"#899418ClinicalTrials.gov
• Drug Use Surveillance of Takecab for "Supplement to Helicobacter Pylori Eradication"#993943ClinicalTrials.gov
• Study of the Use of the Drug Ingaron in Patients With COVID-19#1046268ClinicalTrials.gov
• 21 CFR Part 343 — Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use#506830Code of Federal Regulations (eCFR)
• Integrated Care (iCare) at Mount Sinai to Improve Substance Use Diagnosis and Treatment Practices in HIV Clinic Settings#865784ClinicalTrials.gov
• A Randomized Clinical Trial of a Novel Drug Education and Diversion Program (iDECIDE) for Middle and High School Students#902258ClinicalTrials.gov
• Tezepelumab's Effects on Patient-Reported Symptoms in Severe Asthma, Overall and With History of Comorbid Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)#305445ODU Digital Commons
• Association between gabapentinoid treatment, concurrent use with opioid or benzodiazepine and the risk of drug poisoning: A self-controlled case series study#120110Europe PMC
• State Policy Variation in Implementation of Federal Drug and Child Abuse Laws and Stigmatization of Pregnant and Postpartum Individuals with Opioid Use Disorder.#140798NCBI PubMed Central
• A Comparative Effectiveness Trial of Optimal Patient-Centered Care#811985ClinicalTrials.gov
• A Phase II Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use#830456ClinicalTrials.gov
• DRug Use and Infections in Hai Phong ViEtnam Among Persons Who Inject Drugs#855440ClinicalTrials.gov
• Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter#884218ClinicalTrials.gov
• Belgian Drug-utilization Study to Evaluate the Use of VIMPAT® as Adjunctive Treatment of Partial Onset Seizures in Subjects Aged 16 and Older#891592ClinicalTrials.gov
• Bioavailability of a New Formulation of Nasal Naloxone for Prehospital Use#910972ClinicalTrials.gov
• Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in the Prison Setting#917189ClinicalTrials.gov
• Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease#967552ClinicalTrials.gov